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Transcription from the promoter of mouse mammary tumor virus is subject to both positive and negative
control by cellular factors, and proviral promoter elements that mediate a basal level of transcription must in
some way respond to these cellular regulatory signals. Several such elements, including a TATA box, a region
containing three octamer-related sequences, and a binding site for nuclear factor 1, have been previously
defined. Additional promoter mutations have allowed a fourth basal promoter element to be identified near the
transcription initiation site between +2 and +10. Sequence alterations within this element affect transcription
both in vivo and in vitro. Gel electrophoresis mobility shift and DNase I footprinting assays define a nuclear
protein, termed initiation site-binding protein, that specifically recognizes this region of the promoter. Optimal
levels of transcription from the mouse mammary tumor virus promoter require initiation site-binding protein,
as demonstrated by a correlation between protein affinity and transcriptional activity and by specific inhibition
of transcription in vitro by an oligonucleotide capable of titrating the protein from transcriptionally active
fractions.
Appropriate expression of eukaryotic genes transcribed
by RNA polymerase II is dependent on the interaction of
cis-acting DNA elements with trans-acting, sequence-spe-
cific DNA-binding proteins (for reviews, see references 28,
37, and 53). These cis-acting elements can, in general, be
divided into two nonmutually exclusive classes: promoter
elements that function to define a basal level of transcription
and regulatory elements that function to modulate this basal
activity in either a positive or negative manner. Promoters of
genes transcribed by RNA polymerase II typically include
an A-T-rich element termed the TATA box, located at
approximately -30 to -25 with respect to the start of
transcription (+ 1). This sequence is recognized by transcrip-
tion factor IID (TFIID), and this interaction appears to play
the major role in fixing the site of transcription initiation (41).
Other promoter elements are generally located 5' of the
TATA box within about 100 bp of the transcription start site.
However, there are exceptions to this general organization
(12, 27, 38, 56).
The interaction of basal promoter elements with both
positive and negative regulatory elements has been studied
in several systems. For example, transcription from the
promoter within the long terminal repeat (LTR) of the
proviral DNA of mouse mammary tumor virus (MMTV) is
subject to both positive and negative regulation. Transcrip-
tion is induced by several classes of steroid hormones,
including glucocorticoids (49, 62), progestins (10, 11), and
androgens (10), and the hormone response element that
mediates induction by all of these hormones is located
between about -200 and -80 (25, 32, 36, 48). In addition,
the MMTV LTR contains a distal negative regulatory ele-
ment, located between -427 and -364, which selectively
represses basal activity of the promoter, thus increasing the
ratio of gene expression in the presence and absence of
hormone (24, 33, 40). This element functions in cooperation
with a more promoter-proximal negative regulatory element
centered around -150 and thus located within the hormone
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response element (33). Understanding the molecular details
by which such regulatory elements modulate transcription
depends, ultimately, on defining the mechanisms of basal,
unregulated transcription and elucidating how this basal
transcription responds to both positive and negative regula-
tory signals. To this end, we have recently performed a
detailed mutational analysis of the MMTV promoter, includ-
ing construction of a series of linker-scanning mutations
across the entire promoter region from -100 to + 1 (59). This
analysis revealed several elements that are required for both
basal and glucocorticoid-induced transcription from the pro-
moter. One element contains a TATA box centered at about
-30. A second set of elements is composed of two tandem
10-bp repeats between -60 and -39, within which are three
sequences related to the octamer (16, 46, 59); these octamer-
related sequences were shown to be recognized by a nuclear
protein. A third element contains a recognition sequence for
nuclear factor 1 (NF-1) (13, 14, 44) between -77 and -63.
Here we identify an additional MMTV promoter element
immediately 3' of the transcription initiation site. This ele-
ment is defined by promoter mutations that alter transcrip-
tion from the MMTV promoter in vivo and in vitro. Further-
more, we identify a nuclear protein, which we term the
initiation site-binding protein (ISBP), that recognizes this
element. Correlation of transcriptional activity and ISBP
binding with mutated promoters and inhibition of in vitro
transcription by an oligonucleotide capable of titrating ISBP
from transcriptionally active fractions indicate that ISBP is
required for optimal levels of MMTV promoter activity.
MATERIALS AND METHODS
Plasmids and DNA templates. The construction of pLSwt
has been described elsewhere (59). Plasmid pLS(-2/+6) was
constructed in the same manner as were other linker-scan-
ning plasmids that we have previously described (59). Both
pLSwt and pLS(-2/+6) contain wild-type MMTV se-
quences between -363 and +133, the only difference being
that pLS(-2/+6) contains a synthetic BglII linker which
replaces nucleotides between -2 and +6 relative to the
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transcription initiation site; these MMTV sequences are
linked to coding sequences for chloramphenicol acetyltrans-
ferase (CAT) and the simian virus (SV40) small-t intron and
early poly(A) addition signal. A region of pBR322 DNA
shown to inhibit gene expression in transient transfection
assays (47) has been deleted from the vector sequences in
these plasmids.
Plasmid pT7A5 contains MMTV-CAT coding sequences
inserted into the polylinker of pT7/T3-19 (Promega). The
starting plasmid for this construction was a 5' deletion of the
MMTV promoter with the deletion endpoint at +34 (pA5-58)
(59). This plasmid was digested with SmaI, which cuts
immediately 5' to the MMTV sequences, a HindIII linker
was added at this site, and the plasmid was religated to give
pHA5. This plasmid was digested with HindIII and EcoRI to
give a 350-bp fragment of MMTV-CAT DNA, which was
isolated by gel electrophoresis and ligated into pT7/T3-19
digested with the same enzymes to give pT7A5. This con-
struct allows MMTV-CAT RNA to be synthesized in vitro
by using T7 RNA polymerase under conditions previously
described (60).
Templates for in vitro transcription consisted of isolated
restriction fragments as described in the figure legends.
These template fragments were isolated from 5% polyacryl-
amide gels and quantitated byA260 (e = 20 ml. mg-1 cm-1).
Transfections and CAT assays. Mouse Ltk- cells were
transfected by the DEAE-dextran-dimethyl sulfoxide shock
method (35) as previously described (60) except that 5 x 105
cells per dish were plated the day before transfection. CAT
assays were performed as previously described (60); 40 ,ug of
protein was assayed for 2 h when the extracts were from
cells grown in the absence of hormone, and 5 ,ug was assayed
for 1 h when extracts were from cells treated with 0.1 ,uM
dexamethasone.
Nuclear extracts. Nuclear extracts of tissue culture cells
were prepared by the method of Dignam et al. (15), with a
few previously described modifications (31).
Nuclear extracts of liver cells were prepared from livers
obtained from normal adult cows (Meat Science and Tech-
nology Center, Texas A&M University). Nuclei were pre-
pared from the freshly removed livers by the method of
Lichtsteiner et al. (34), with the following modifications. All
operations were performed at 0 to 4°C. Liver (200 g) was
minced and combined with 1 liter of homogenization buffer
in a Waring blender. The blender was filled to the brim with
buffer and sealed with Parafilm to exclude air and prevent
the generation of foam. Leupeptin (1 ug/Iml), pepstatin A (1.7
p,g/ml), and phenylmethylsulfonyl fluoride (0.5 mM) were
added to the nuclear lysis buffer. After isolation of the nuclei
and extraction of the nuclear proteins, the protein pellet was
resuspended in a minimal volume of buffer TMO.1 M (15) (50
mM Tris-HCl [pH 7.9], 20% glycerol, 1.0 mM EDTA, 1.0
mM dithiothreitol [DTT], 0.1 M KCl). The extract was
dialyzed against two changes of 600 ml of the same buffer for
at least 2 h for each change. The precipitate that formed
during dialysis was removed by centrifugation. Protein con-
centration was determined by the method of Bradford (7)
(Bio-Rad), with bovine serum albumin as the standard. The
extract was divided into aliquots, quick-frozen in liquid
nitrogen, and stored at -70°C.
Fractionation of nuclear extracts. Liver nuclear extracts
were fractionated by two different protocols, both of which
were originally developed for HeLa cell nuclear extracts.
The first protocol was adapted from Tsai et al. (61). Nuclear
extract was dialyzed against buffer A (20 mM N-2-hydroxy-
ethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.9],
20% glycerol, 0.1 mM EDTA, 5 mM MgCl2, 2 mM DTT)
containing 50 mM (NH4)2SO4 and loaded onto a DEAE-
Sephadex column. The flowthrough fraction (DE50) was
collected, and two additional fractions were obtained by step
elution with buffer A containing 175 mM (NH4)2SO4 (DE175)
and then with buffer A containing 500 mM (NH4)2SO4
(DE500). All three fractions were concentrated by
(NH4)2SO4 precipitation; the DE175 and DE500 fractions
were redissolved in buffer A, dialyzed, and aliquoted for
storage at -70°C. The DE50 fraction was redissolved and
dialyzed against buffer B (20 mM HEPES [pH 7.9], 20%
glycerol, 0.2 mM EDTA, 2 mM DTT) containing 100 mM
NaCl and loaded onto a phosphocellulose column (Whatman
P-li). The column was washed with the same buffer to
collect a flowthrough fraction (DE50.PC100), and three
additional fractions were obtained by step elution with buffer
A containing 250 mM KCl (DE50.PC250), 600 mM KCl
(DE50.PC600), and 1 M KCl (DE50.PC1000). These frac-
tions were concentrated by (NH4)2SO4 precipitation; protein
was redissolved in buffer A containing 100 mM KCl, dia-
lyzed, and aliquoted for storage at -70°C. All procedures
were carried out at 0 to 4°C. Transcription from the MMTV
promoter was reconstituted with the DE175, DE500, and
DE50.PC600 fractions. The relative amounts of these frac-
tions required for optimal MMTV promoter activity varied
somewhat among different preparations.
The second fractionation protocol was based on that
described by Dignam et al. (15). Liver nuclear extracts in
buffer TMO.1M were loaded on a phosphocellulose column
(Whatman P-il) at a ratio of 15 to 20 mg of protein per ml of
packed resin. The column was washed with the same buffer
to collect a flowthrough fraction (PC100), and three addi-
tional fractions were obtained by step elution with buffer TM
containing total KCl concentrations of 300 mM (PC300), 500
mM (PC500), and 1.0 M (PC1000). These fractions were
concentrated by (NH4)2SO4 precipitation; protein was redis-
solved in buffer TMO.lM, dialyzed, and aliquoted for storage
at -70°C. All procedures were carried out at 0 to 4°C.
Transcription from the MMTV promoter was reconstituted
with the PC100, PC500, and PC1000 fractions.
Further purification of ISBP from the PC1000 fraction was
carried out by sequence-specific DNA affinity chromatogra-
phy (29). Approximately 300 ,ug of complementary 33-bp
oligonucleotides encompassing MMTV sequences from -16
to + 17 (Fig. 1A) were phosphorylated with ATP and T4
polynucleotide kinase (Bethesda Research Laboratories)
and allowed to hybridize. The double-stranded oligonucle-
otides were concatamerized (T4 ligase; 20,000 U/,l; New
England Biolabs) by way of BglII-BamHI overhangs to give
unidirectional oligomers (50) with an average size of 200 bp
(6-mer), as determined on a 4% polyacrylamide gel. The
DNA was covalently attached to CNBr-activated Sepharose
CL-2B resin (Pharmacia) as described previously (1). The
PC1000 fraction [containing poly(dI. dC) as nonspecific
DNA in an amount determined by the method of Kadonaga
and Tjian (29)] was loaded on this column, which was
washed with TMO.1 M containing 0.1% Nonidet P-40 (NP-
40) and then with 1 M KCI in TM buffer containing 0.1%
NP-40. Fractions (0.2 ml) were collected, and aliquots were
tested for ISBP activity by gel electrophoresis mobility shift
assay. Active fractions were pooled and applied to a second
DNA affinity column, which was run identically to the first.
Active fractions from the second column were concentrated
and dialyzed against TMO.1 M containing 0.1% NP-40, and
aliquots were frozen and stored at -70°C.
In vitro transcription. The transcription procedure in-
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FIG. 1. (A) Sequence of MMTV promoter mutations near the
transcription initiation site. The MMTV LTR is depicted as a box
with several restriction sites and the locations of the HRE, proximal
negative regulatory element (pNRE), and distal negative regulatory
element (dNRE) indicated. Plasmid pLSwt (59) contains LTR se-
quences from -363 (RsaI) to +133 (PvuII) linked to a CAT reporter
gene. The MMTV promoter contains a binding site for NF-1, three
octamer-related sequences, and a TATA element (59). Promoter
mutations near the initiation site are shown as shaded letters. The
black bar (-16 to +17) defines the oligonucleotide used for gel
electrophoresis mobility shift and transcription competition experi-
ments. (B) CAT expression from mutated promoters. Plasmids
containing MMTV promoter mutations were transfected into mouse
Ltk- cells, and CAT expression was determined in the presence and
absence of the synthetic glucocorticoid dexamethansone (dex). CAT
expression from the mutated promoters was normalized to that
obtained from LSwt, and the normalizations were performed sepa-
rately for expression in the presence and absence of hormone. Each
bar reflects an average of three to six independent transfections with
a standard error of less than 20% of the mean. Absolute levels of
CAT expression in extracts of cells transfected with LSwt were 0.13
and 5.38 nmol * min-' mg-' in the absence and presence of
hormone, respectively.
cluded a 30-min preincubation of DNA with nuclear extract
fractions at 30°C followed by the addition of ribonucleoside
triphosphates and a second 30-min incubation to allow for
runoff transcription (21, 22). The preincubation was per-
formed in 20 p.l containing extract fractions as indicated in
the figure legends and 100 ng of template DNA unless
otherwise indicated. Buffer conditions were 12mM Tris-HCI
(pH 7.9), 12% glycerol, 60 mM KCI, 0.1 mM EDTA, and 10
mM MgCl2 (including contributions made by the extract).
After 30 min at 30°C, 10 U of RNasin (Promega) was added
along with nucleotides to final concentrations of 600 p.M
ATP, CTP, and GTP and 50 p.M [a-32P]UTP (8 Ci/mmol,
final specific activity), bringing the final volume to 25 p.l.
Reactions were terminated by the addition of 50 pl of 10 mM
EDTA, 0.1 M sodium acetate (pH 5.5), 0.5% sodium dodecyl
sulfate (SDS), and 1 mg of yeast tRNA per ml and then
extracted with 75 p,l of buffered phenol-chloroform (2:1).
The organic phase was reextracted with 25 p,l of transcrip-
tion stop buffer, and the aqueous phases were combined and
precipitated with 2.5 volumes of ethanol. Pellets were
washed with 70% ethanol and resuspended in 5 pl of 98%
formamide plus tracking dyes. Transcripts were subjected to
electrophoresis on a 6% polyacrylamide gel containing 7 M
urea. Running buffer contained 0.09 M Tris base, 0.09 M
borate, and 2.5 mM EDTA. Gels were exposed to Kodak
XAR-5 film (Eastman Kodak Co.), at -70°C with an inten-
sifying screen. RNA generated by T7 RNA polymerase from
pT7A5 in the presence of [a-3 PIUTP (0.1 Ci/mmol) was
added to the transcription reactions with the stop buffer and
served to standardize recoveries of the specific transcript
during preparation for electrophoresis. Transcription was
quantitated by excising bands from the dried gel and scintil-
lation counting, by film densitometry, or by way of a
Betagen blot analyzer.
The sequence of the double-stranded, nonspecific oligo-
nucleotide used in the competition experiment described in
Fig. 7 was 5'-GATCCAGTCTGATCAGACTGGATC-3'.
Gel electrophoresis mobility shift assay. Complementary
33-bp oligonucleotides spanning the MMTV transcription
initiation site (-16 to +17) were synthesized on an Applied
Biosystems DNA synthesizer (Oligonucleotide Synthesis
Services, Department of Biochemistry and Biophysics,
Texas A&M University). Equal molar amounts of the com-
plementary strands were mixed and annealed by heating at
100°C for 2 min and cooling slowly to room temperature.
Binding experiments were performed by incubating probe
(0.5 to 1.0 ng, 5,000 to 10,000 Cerenkov cpm) labeled with T4
polynucleotide kinase and [_y-32P]ATP (3,000 Ci/mmol; New
England Nuclear) with the indicated amount of protein for 15
min on ice in 15 plI of buffer containing 50 mM Tris-HCl (pH
7.9), 1.0 mM EDTA, 12.5 mM MgCl2, 20% glycerol, 1.0 mM
DTT, 1 p,g of poly(dI- dC), and 0.1 M KCI. The mixture was
then loaded on a 4% polyacrylamide gel containing 0.1 M
Tris-borate buffer (pH 8.3), 2 mM EDTA, and 10% glycerol
and electrophoresed at 4°C at 20 V/cm in the same buffer
without glycerol. Gels were exposed to Kodak XAR-5 film
for 24 h at -70°C with an intensifying screen. When a
competitor was used, the competitor DNA was added to the
extract-buffer mixture and incubated on ice for 10 min, the
labeled DNA was then added, and incubation continued for
an additional 15 min.
DNase I footprinting. Radioactively labeled DNA probes
contained MMTV sequences from position -69 to + 105 and
were generated by the polymerase chain reaction, using
plasmid pLSwt (59) as a template. For each footprinting
probe, one oligonucleotide primer was 5' end labeled with
[-y-32P]ATP (6,000 Ci/mmol) and T4 polynucleotide kinase.
Size markers were prepared by subjecting a portion of the
probe to Maxam and Gilbert DNA sequencing (39) as
modified by Bencini et al. (4).
DNase I footprinting reactions were done in a total volume
of 20 pl in a mixture containing 50 mM Tris-HCl (pH 7.9), 1
mM EDTA, 1 mM DTT, 12.5 mM MgCl2, 100 mM KCl, and
20% (vol/vol) glycerol, with 1 p.g poly(dI- dC), 9 fmol of
polymerase chain reaction-generated probe (1,000 to 5,000
cpm/fmol), and ISBP that had been purified over two se-
quential sequence-specific DNA affinity columns. Binding
reaction mixtures were incubated for 40 min at room tem-
perature and then for 10 min on ice. Two units of pancreatic
v
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DNase I (RNase free; U.S. Biochemical) was added, and the
reaction mixtures were incubated for 2 min on ice and then
stopped by adding 110 ,ul of a solution containing 0.1 M
sodium acetate (pH 5.2), 10 mM EDTA, 0.1% (wt/vol) SDS,
and 20 ,ug of tRNA per ml. The samples were phenol-
chloroform extracted, and the DNA was precipitated with
ethanol. Samples were resuspended in a mixture of 80%
(vol/vol) formamide, 10 mM NaOH, 1 mM EDTA, and 0.1%
(wtlvol) each xylene cyanol and bromphenol blue. Samples
were fractionated on a 6% polyacrylamide gel containing 7 M
urea, 90 mM Tris-borate, and 2 mM EDTA. The gel was
fixed in 5% (vol/vol) methanol and 5% (vol/vol) acetic acid
for 20 min, dried, and exposed to XAR-5 film with an
intensifying screen for 2 to 4 days.
RESULTS
Mutations near the transcription start site decrease the
activity of the MMTV promoter. Our previous linker-scan-
ning analysis of the MMTV promoter extended from approx-
imately -100 to the transcription initiation site (59). This
analysis revealed no functional promoter elements 3' of the
TATA box. Subsequent experiments, in which we observed
decreased transcription from the MMTV promoter when
sequences at or immediately 3' of the transcription initiation
site were altered, led us to investigate this region of the
MMTV LTR more systematically. To this end, we con-
structed two additional linker-scanning mutations in the
MMTV promoter by recombining 5' and 3' deletions such
that 8 bp of MMTV DNA were replaced by a synthetic BglII
linker (AAGATCTT) as we have previously described (59).
These mutated promoters were designated LS(-2/+6) and
LS(+11/+18), where the numbers in parentheses indicate
the nucleotides replaced by the BglII linker (Fig. 1A). As in
our previous linker-scanning mutations, these constructions
contain MMTV sequences from -363 (RsaI) to +133 (PvuII)
linked to the coding sequences for CAT followed by the
SV40 small-t intron and sequences required for poly(A)
addition (59). The vector sequences contained a deletion of a
region of pBR322 which has been shown to inhibit transient
gene expression (47). These plasmids were transfected into
mouse Ltk- cells by the DEAE-dextran-dimethyl sulfoxide
shock procedure (35) as described in detail elsewhere (60).
Sixty hours after shock, cells were harvested and crude
extracts were assayed for CAT activity (60) and total protein
(7). CAT expression from LS(-2/+6) was about six times
lower than that from the wild-type promoter in LSwt (Fig.
1B), while adjacent linker-scanning mutations LS(-7/+1)
(59) and LS(+11/+18) had comparatively little effect.
Since the LS(-2/+6) promoter contains five mutated
bases downstream of the normal transcription start site, the
mRNA transcribed from this promoter would be expected to
be altered relative to the wild-type transcript. Thus, the
observed decrease in CAT activity may not be due solely to
changes in transcriptional activity but may also reflect al-
tered RNA stability or efficiency of CAT translation relative
to LSwt.
To determine whether the MMTV promoter mutation in
LS(-2/+6) did, indeed, alter transcriptional efficiency of the
promoter, we turned to in vitro transcription assays. An
efficient in vitro assay for MMTV promoter activity was
developed from fractionated bovine liver nuclear extracts.
Extracts were prepared from fresh liver by a procedure
slightly modified from that of Lichtsteiner et al. (34). The
MMTV promoter was not transcribed in these crude ex-
tracts, but transcription could be obtained after minimal
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FIG. 2. In vitro transcription from the MMTV promoter. An
isolated MMTV fragment (-105 to +248) was used as a template in
a transcription system reconstituted from nuclear extracts of bovine
liver. Transcription reaction mixtures contained the following
amounts of protein from extract fractions (see Materials and Meth-
ods): 1.5 jig of DE175, 9 jg of DE500, and 27 ,ug of DE5O.PC600.
(A) Electrophoretic analysis of transcription products. Template
concentrations were 6.6 (lane 1), 3.3 (lane 2), 1.7 (lane 3), 0.8 (lane
4), 0.4 (lane 5), 0.2 (lane 6), and 0.1 (lane 7) j±g/ml. Lane M contained
size markers consisting of 32P-labeled fragments from a Mspl
digestion of pBR322 DNA. (B) Template dependence of transcrip-
tion. Bands were excised from the dried gel shown in panel A and
counted. nt, nucleotides.
fractionation and reconstitution by either of two procedures
involving fractionation by DEAE-Sephadex and phosphocel-
lulose or by phosphocellulose alone (see Materials and
Methods).
With the transcription system reconstituted from DEAE-
Sephadex and phosphocellulose fractions and a transcription
template composed of an isolated DNA fragment extending
from -105 to +248 of the MMTV LTR, a runoff transcript of
the appropriate size which was dependent on template
concentration was detected (Fig. 2). Appearance of this
transcript was sensitive to low levels of a-amanitin (0.2
,ug/ml), and its synthesis was dependent on each of the three
fractions used in the reconstitution (data not shown). A
similar template fragment extending only to + 133 yielded the
expected shorter runoff transcript (Fig. 3), confirming the
specificity of transcription initiation. As further confirmation
that the observed in vitro transcription accurately reflects
activity of the MMTV promoter, we assayed several tran-
scription templates containing linker-scanning mutations in
the MMTV promoter. Mutations in the binding site for NF-1
[LS(-65/-58)] and the TATA box [LS(-36/-29)] decreased
in vitro transcription to 23 and 7%, respectively, of the level
obtained with the wild-type promoter (Fig. 4); these activi-
ties roughly correspond to the relative in vivo transcriptional
activities of promoters with these mutations (59). Quantita-
tive assessments of transcription in vitro were made by
normalizing results to those for a 32P-labeled internal stan-
dard RNA of 370 nucleotides added immediately after com-
pletion of the transcription reactions; this standard RNA
served to normalize for differential recovery of samples
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FIG. 3. Synthesis of appropriately sized transcripts in the recon-
stituted transcription system. Two isolated MMTV DNA fragments,
one containing sequences from -105 to +248 (lanes 1 and 2) and the
other containing sequences from -105 to + 133 (lanes 3 and 4), were
used as templates in the in vitro transcription system reconstituted
from bovine liver nuclear extracts. Template concentrations were
1.8 p.g/ml (lanes 1 and 3) and 3.6 ,ug/ml (lanes 2 and 4). Lane M
contained size markers as described in legend to Fig. 1. Transcrip-
tion reaction mixtures contained the following amounts of protein
from extract fractions (see Materials and Methods): 13 pg of DE175,
3.5 ,ug of DE500, and 6 ,g of DE50.PC600. nt, nucleotides.
during preparation for electrophoretic analysis (see Materi-
als and Methods).
To determine whether MMTV sequences near the tran-
scription initiation site contribute to promoter activity, in
vitro transcription from the LS(-2/+6) mutant promoter
was assessed (Fig. 4). Transcript accumulation from the
mutated template was decreased to approximately 50% of
the wild-type level. This decreased accumulation could be
the result of decreased transcriptional activity of the mutated
promoter or to differential stabilities of the RNAs derived
from the wild-type and mutated templates. The contribution
of differential RNA stability was determined by comparing
the stabilities of transcripts from the wild-type and LS(-2/
+6) templates in the reconstituted extract fractions. After
c
o100-
0.
COL- 50-
(DCu
A Template
FIG. 4. In vitro transcription of mutated MMTV promoters.
MMTV promoter templates (3.6 pLg/ml) containing linker-scanning
mutations were transcribed in vitro, and transcripts were quanti-
tated by densitometry of exposed films after gel electrophoresis and
autoradiography. A labeled internal standard RNA generated by T7
RNA polymerase was added to each sample to normalize recovery.
Template activity is presented relative to that of the MMTV
wild-type promoter. Transcription of templates containing muta-
tions in the NF-1 binding site [LS(-65/-58)] and TATA box
[LS(-31/-24)] (59) as well as the transcription initiation site
[LS(-2/+6); Fig. 1] are shown. Reaction mixtures contained extract
fractions as described in the legend to Fig. 3.
synthesis of transcripts in vitro, a-amanitin (2 ,ug/ml) was
added to prevent further RNA synthesis. At 10-min inter-
vals, aliquots were removed from each reaction mixture and
processed. After 40 min, there was no preferential degrada-
tion of the RNA from the LS(-2/+6) template (data not
shown). The decreased transcript accumulation observed
with the LS(-2/+6) template is therefore due to altered
transcriptional activity of the mutated promoter.
A nuclear protein recognizes sequences near the MMTV
transcription initiation site. Decreased transcription from the
MMTV promoter in LS(-2/+6) could be the result of altered
recognition by a sequence-specific DNA binding protein. As
initial experiments to identify protein(s) that specifically
recognize sequences near the MMTV transcription initiation
site, we performed a series of gel electrophoresis mobility
shift assays (17, 19). A 33-bp synthetic oligonucleotide that
contained MMTV sequences from -16 to +17 was synthe-
sized (Fig. 1A); this DNA was 5' end labeled with 32P and
incubated with nuclear extracts derived from various
sources. These experiments revealed a specific binding
activity in nuclear extracts from bovine liver as well as HeLa
and Ltk- cells, all sources in which the MMTV promoter is
transcriptionally active. An example of our results is shown
in Fig. 5, in which HeLa cell nuclear extracts generate three
bands of retarded electrophoretic mobility indicative of
protein-DNA complexes. At least one of these complexes
(labeled C2 in Fig. 5) is specific, as determined by the criteria
of susceptibility to competition by excess unlabeled probe
oligonucleotide (Fig. 5A, lanes 3 to 7) but relative resistance
to competition by an oligonucleotide of similar length con-
taining a binding site for NF-1 (lanes 8 to 10). Comparable
results have been observed with nuclear extracts from
bovine liver and Ltk- cells (data not shown). In more
purified fractions containing binding activity specific for this
oligonucleotide, only a single shifted band is observed with a
mobility comparable to that of complex C2 (data not shown).
If any of the complexes detected by the mobility shift
assay are relevant in transcription from the MMTV pro-
moter, the ability of the proteins present in such complexes
to recognize mutated promoters with decreased transcrip-
tional activity such as LS(-2/+6) would be expected to be
altered. To test this prediction, we used LSwt or LS(-2/+6)
as a competitor in gel mobility shift experiments (Fig. SB).
The wild-type sequences in LSwt (lanes 3 to 6) were much
more efficient in competing for complexes with the 33-bp
labeled probe than were the mutated sequences in LS(-2/
+6) (lanes 7 to 10). Interestingly, the linearized LSwt
plasmid competitor (Fig. SB) was apparently more efficient
than the initiation site oligonucleotide competitor (Fig. 5A);
this observation may reflect differences in the binding of
ISBP to its recognition site in these different sequence
contexts. Overall, these results establish a correlation be-
tween protein binding to sequences near the MMTV tran-
scription initiation site and promoter activity. For ease of
discussion, we term any such protein(s) ISBP.
To further localize the MMTV sequences recognized by
ISBP, we used DNase I footprint analysis. These experi-
ments were performed with ISBP that was partially purified
from bovine liver nuclear extracts by phosphocellulose and
sequence-specific DNA affinity chromatography (29). Pro-
tection by ISBP was observed surrounding the start of
transcription on both the template and nontemplate DNA
strands (Fig. 6). The footprint extended from -2 to +10 on
the template strand and from -5 to +11 on the nontemplate
strand. A DNase I-hypersensitive site was observed at -10
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A A
B
FIG. 5. Binding of a nuclear protein to the MMTV promoter near
the transcription initiation site. (A) Specific binding assessed by
competition. A double-stranded oligonucleotide containing MMTV
sequences from -16 to + 17 was 32P labeled and used as a probe in
a gel electrophoresis mobility shift assay with protein from a nuclear
extract of HeLa cells (1 ,ug). Unlabeled, double-stranded competitor
DNAs used to assess the specificity of protein-DNA complexes
were the MMTV initiation site (-16 to + 17) oligonucleotide (lanes 3
to 7) and an oligonucleotide containing a binding site for NF-1 (lanes
8 to 10). Competitor concentrations were 10 (lanes 3 and 8)- 25 (lane
4)-, 100 (lanes 5 and 9)-, 250 (lane 6)-, and 1,000 (lanes 7 and 10)-fold
molar excess over the labeled probe. Lane 2 had no competitor, and
lane 1 contained no extract. (B) Alteration of protein recognition by
MMTV promoter mutations in LS(-2V+6). The MMTV initiation
site oligonucleotide (-16 to + 17) was used as a probe in a mobility
shift assay with protein from a nuclear extract of HeLa cells (1 ,ug).
Unlabeled competitor DNAs were linearized plasmids LSwt (lanes 3
to 6) and LS(-2/+6) (lanes 7 to 10). Competitor concentrations were
50 (lanes 3 and 7)-, 100 (lanes 4 and 8)-, 150 (lanes 5 and 9)-, and 250
(lanes 6 and 10)-fold molar excess over the labeled probe. Lane 2
had no competitor, and lane 1 contained no extract.
on the template strand (arrow in Fig. 6A). No protection was
seen over the TATA box on either strand.
ISBP is necessary for efficient MMTV transcription in vitro.
Our results thus far indicate that MMTV promoter se-
quences near the transcription initiation site are required for
efficient promoter activity in vitro and in vivo and that one or
more nuclear proteins which we have termed ISBP recog-
nize these sequences. To further test the idea that ISBP is
required for MMTV promoter activity, the 33-bp double-
stranded oligonucleotide (-16 to +17 of the MMTV LTR)
used as a probe in the mobility shift assays (Fig. 5) was used
as a competitor in in vitro transcription experiments. The
premise of these experiments is that if ISBP is important for
transcription, adding increasing amounts of the oligonucle-
otide will titrate out ISBP and transcription will decrease.
Preincubation of transcription assays with the 33-bp initi-
ation site oligonucleotide (-16 to +17) resulted in a se-
quence-specific decrease in transcription (Fig. 7). Inclusion
of a comparably sized oligonucleotide with no known protein
ISBP
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FIG. 6. DNase I footprint of ISBP. The footprinting probes
contained MMTV sequences from -69 to +105, with the 5' end
label on the template strand at +105 (A) or on the nontemplate
strand at -69 (B). Probe DNA was incubated with no protein (lanes
3) or with partially purified ISBP isolated by phosphocellulose and
sequence-specific DNA affinity chromatography (0.1 p,l [lanes 4] or
1 ,ul [lanes 5]). DNase I digestions were performed, and the products
are shown after fractionation by denaturing polyacrylamide gel
electrophoresis and autoradiography. Alignment of the cleavage
pattern with the MMTV promoter sequence was accomplished with
chemical sequencing reactions of the probe DNAs (lanes 1 and 2).
Protected sequences are indicated by brackets. The arrow in panel
A indicates a DNase I-hypersensitive site at -10.
binding site had little effect on transcription at the concen-
trations tested. We conclude from these experiments that
titration of ISBP leads to a significant loss of MMTV
promoter activity in vitro.
DISCUSSION
Efficient transcription from the MMTV promoter requires
sequences near the transcription initiation site. Previous mu-
tational analysis of the MMTV promoter defined a TATA
element, several octamer-related sequences, and a binding
site for NF-1 as critical for both basal and steroid hormone-
induced transcription (59). We have shown here that in
addition to these elements, efficient transcription from the
MMTV promoter requires sequences near the transcription
initiation site. Linker-scanning mutations in this region of
proviral DNA were shown to affect expression of a linked
CAT reporter gene (Fig. 1), and comparison of mutant and
wild-type templates in an in vitro transcription assay verified
that sequences near the transcription start site are necessary
for optimal promoter activity (Fig. 4). This element appears
to play a role in basal as well as hormone-induced transcrip-
tion, since both were affected by these mutations in vivo.
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FIG. 7. Oligonucleotide titration of ISBP from the MMTV pro-
moter. Competitor DNAs were added to transcription reactions
during the preincubation of transcription factors with an MMTV
template containing sequences from -105 to +248. Competitors
consisted of oligonucleotides containing a binding site for ISBP
(MMTV sequences from -16 to +17) (solid symbols) or a compa-
rably sized oligonucleotide containing no known protein binding site
(open symbols). Transcriptional activity is shown relative to that
obtained in the absence of competitor. A labeled internal standard
RNA generated by T7 RNA polymerase was added to each sample
to normalize recovery. Transcription reaction mixtures contained
the following amounts of protein from extract fractions (see Mate-
rials and Methods): 12 pg of PC100, 7 pLg of PC500, and 1 p.g of
PC1000.
The linker-scanning analysis demonstrated that mutations in
LS(-7/+1) and LS(+11/+18) had relatively little effect on
transcription, while those in LS(-2/+6) decreased promoter
activity. These experiments localized the functional pro-
moter element to nucleotides between +2 and +10.
ISBP is required for efficient MMTV promoter activity.
Electrophoresis mobility shift and DNase I footprinting
experiments identified a protein (ISBP) that specifically
protects MMTV promoter sequences between -5 and +11
from DNase I cleavage (Fig. 5 and 6). The binding of ISBP to
the MMTV promoter is decreased in LS(-2/+6), thus cor-
relating the transcriptional effect with the observed binding
of ISBP (Fig. 5B). In addition, a requirement for ISBP
binding for efficient MMTV promoter activity was demon-
strated in a competition assay in which a synthetic oligonu-
cleotide containing MMTV sequences from -16 to + 17 was
shown to specifically inhibit promoter activity in vitro,
presumably by titrating out ISBP and making it unavailable
to interact with the transcription template (Fig. 7).
A number of studies have shown that binding of TFIID
and other basal transcription factors to the promoter can
result in nuclease protection of sequences spanning the
transcription initiation site. For example, studies on the
histone H4 (20, 41) and several heat shock (20, 41) gene
promoters, as well as the adenovirus major late (20, 54) and
E4 (23) promoters, have shown that DNase I protection
resulting from TFIID binding extends through the initiation
site as far downstream as +35 (23, 41, 54). This downstream
protection has been ascribed to weak, nonspecific interac-
tions of TFIID which are stabilized once other transcription
factors, along with RNA polymerase, are incorporated into
the preinitiation complex (20, 63). Related observations have
been made with MMTV; a phosphocellulose column frac-
tion, presumably containing TFIID, has been shown to bind
to a region of the MMTV promoter containing the TATA
element by exonuclease III and DNase I protection assays
and to extend weak DNase I protection as far downstream as
+37 (13). This protection is similar to what we observe with
use of an unfractionated nuclear extract (data not shown).
However, there are several lines of evidence indicating that
our results defining ISBP are not manifestations of TFIID
binding at the MMTV TATA box. First, ISBP binding
activity in crude nuclear extracts is specific for MMTV
sequences between -16 and +17 (Fig. 5), a region which
does not contain the MMTV TATA box, and our most
purified fraction containing ISBP does not footprint over the
TATA element. In addition, a direct competition experiment
with an oligonucleotide containing the MMTV TATA region
(-42 to -18) in a mobility shift assay showed that these
sequences had no effect on the ability of ISBP to recognize
sequences near the MMTV transcription initiation site (data
not shown). Moreover, we have demonstrated that ISBP
binding can be disrupted by introducing a clustered set of
point mutations near the initiation site (Fig. SB). Finally,
exonuclease III protection experiments by Cordingley et al.
(14) in isolated nuclei revealed a broad protected region in
the MMTV promoter extending to +12, while exonuclease
III protection of a TFIID-containing phosphocellulose col-
umn fraction from a nuclear extract could be demonstrated
only to -4 (13). It is possible that the discrepancy between
the results with isolated nuclei and fractionated nuclear
extracts reflects the loss of ISBP in the tested extract
fractions.
Relationship ofMMTV ISBP binding site to other promoter
elements. The location of the MMTV promoter element
identified here is reminiscent of the promoter element
termed the initiator (Inr), originally defined in the TATA-less
promoter of the terminal deoxynucleotidyltransferase (TdT)
gene (56). The Inr element is able to specify accurate but
inefficient transcription initiation in the absence of any
additional promoter element and is able to direct a high level
of accurately initiated transcription in conjunction with
appropriately located binding sites for transcription factors
(45, 56, 57, 64). A functionally homologous element of
similar sequence has also been identified at the transcription
initiation site of the adenovirus major late promoter (56),
indicating that Inr sequences are not restricted to TATA-less
promoters. Within the context of the TdT gene, the Inr has
been defined as CTCANTCT, with transcription initiation
occurring at the adenine (57). However, the C at position -3
can be changed to an A without seriously destroying Inr
function, and the TCT at positions +3 to +5 can be changed
to AGA with retention of at least partial Inr function (57). A
protein termed TFII-I has been shown to bind to Inr se-
quences in the adenovirus major late, TdT, and human
immunodeficiency virus type 1 promoters (51). TFII-I also
recognizes a binding site for the transcription factor USF,
and the two proteins bind cooperatively to sites on the
adenovirus major late promoter (51).
A number of genes have been shown to contain function-
ally defined promoter elements at or near their transcription
initiation sites which bear some sequence similarity to the
Inr. These include the Drosophila gypsy retrotransposon
(26) as well as the genes encoding porphobilinogen deami-
nase (3), glial fibrillary acidic protein (42, 43), and myelin
basic protein (58). In a number of these promoters, proteins
that bind specifically to the Inr-related sequences have been
identified. The extent to which the elements in these pro-
moters are mechanistically homologous to the Inr element
has not yet been determined.
The relationship of the MMTV initiation site element to
the Inr is not clear. Sequences immediately surrounding +1
of the MMTV promoter bear no similarity to the Inr, but an
random
ISBP
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Inr-related sequence (AACAGTCC) is located between +3
and +10, overlapping both the functionally defined MMTV
promoter element and the ISBP binding site.
Several proteins, in addition to TFII-I, have been shown
to recognize sequences near the transcription initiation sites
of one or more promoters. For example, a protein termed
cap-binding factor (CBF) has been found in extracts of
human K562 cells and footprints on the adenovirus major
late promoter between +1 and +23; methylation interfer-
ence assays demonstrated that sequences from +10 to +12
are important in CBF binding (18), suggesting that its func-
tion may not be related to the major late promoter Inr
element. The sequence of the CBF binding site is not
strikingly similar to the ISBP binding site in MMTV, and the
differing chromatographic properties of the two proteins (18)
make it extremely unlikely that ISBP and CBF are the same
protein.
DNA sequences corresponding to the promoter-proximal
5' untranslated leader regions of human immunodeficiency
virus types 1 and 2 have been shown to interact with a
transcription factor termed leader-binding protein 1 (LBP-1)
(27). In crude nuclear extracts, LBP-1 binding is required for
optimal levels of basal transcription from the proviral pro-
moters (27). However, with a more purified transcription
system, this effect is less apparent and high levels of LBP-1
actually repress transcription, presumably by competing
with TFIID for binding to the TATA region (30). The LBP-1
binding site has been defined as CPyAG(A/T), a sequence
which is potentially related to the central core of the Inr
sequence (CICANTCT) and to MMTV sequences within the
ISBP binding site from +4 to +8 (ACAGT). However,
LBP-1 does not recognize the Inr element of the adenovirus
major late promoter (30).
A promoter element near the transcription initiation site in
the murine dihydrofolate reductase (DHFR) gene that is
necessary for both efficient and accurately initiated tran-
scription has also been defined, and a nuclear protein has
been shown to footprint on the DHFR promoter between
-11 and +9 (38). A similar sequence was observed near the
major transcription initiation site for the SV40 late promoter,
and a protein in crude nuclear extracts was shown to
footprint on SV40 sequences between about -7 and +18,
overlapping the region of sequence similarity with DHFR.
These SV40 sequences were shown previously by muta-
tional analysis to be required for efficient transcription
initiation from the late promoter (2). The relationship be-
tween the DHFR and SV40 elements was further strength-
ened by the observation that a concatemerized oligonucle-
otide corresponding to DHFR sequences between -16 and
+9 was able to inhibit in vitro transcription from the SV40
late promoter, presumably by competing for a transcription
factor required to bind near the SV40 transcription initiation
site. Both the DHFR and SV40 late promoters lack TATA
boxes and are similar in structure to the promoters of a
number of so-called housekeeping genes. Because somewhat
related sequences can be identified near the transcription
initiation sites for several such promoters (although their
functional significance has not been tested), the protein that
binds near the DHFR (and presumably SV40 late) transcrip-
tion initiation sites has been termed housekeeping initiation
protein 1 (38). Further studies strongly suggested that this
protein is identical to the cellular transcription factor E2F (5,
6). MMTV sequences protected by ISBP are not particularly
related to the E2F consensus binding site (TlITCGCGC), but
the E2F site in the SV40 late promoter (TlTCAGGCC)
contains a five-of-six match to MMTV sequences between
+5 and +10 (CAGTCC) at exactly the same position relative
to the transcription initiation site. However, our preliminary
experiments suggest that an oligonucleotide containing an
E2F consensus binding site does not efficiently compete with
MMTV sequences for ISBP (data not shown).
Potential roles of ISBP in MMTV transcription initiation.
Transcription initiation is a complex process that involves a
large number of protein-DNA and protein-protein interac-
tions. It is tempting to speculate that the position of ISBP
binding near the transcription initiation site in the MMTV
promoter relates to the melting of the two DNA strands at
the transcription initiation site leading to the formation of an
open transcription complex in which the template strand of
the DNA is accessible to RNA polymerase. Alternatively,
ISBP may stabilize other factors needed for transcription
through protein-protein interactions. This type of function
has been shown to be the case for the glial fibrillary acidic
promoter in which a downstream element is required for
stable binding of TFIID (43). In addition, CBF has been
shown to stabilize TFIID binding to the adenovirus major
late promoter and may be associated with TFIID prior to
template binding (52). While there are relatively few docu-
mented cases of promoter elements 3' to + 1 having an effect
on a known transcription factor, numerous proteins are
known to bind 5' to the TATA element and stabilize basal
transcription factors within the transcription initiation com-
plex (8, 9, 23, 55). Precise definition of the mechanistic role
of ISBP in MMTV transcription initiation and the relation-
ship of ISBP to proteins involved in transcription from other
promoters will require further biochemical studies with the
purified protein.
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